高级检索
当前位置: 首页 > 详情页

Tenascin-C Promotes Tumor Cell Migration and Metastasis through Integrin α9β1-Mediated YAP Inhibition

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE ◇ 自然指数

单位: [1]INSERM, Hop Civil, Inst Hematol & Immunol, U1109,MN3T, Strasbourg, France [2]Univ Strasbourg, Strasbourg, France [3]Univ Strasbourg, LabEx Medalis, Strasbourg, France [4]FMTS, Strasbourg, France [5]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Tongji Canc Res Inst,Wuhan,Hubei,Peoples R China [6]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Dept Gastrointestinal Surg,Wuhan,Hubei,Peoples R China [7]Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England [8]Porsolt, Res Lab, F-53940 Le Genest St Isle, France
出处:
ISSN:

摘要:
Tenascin-C is an extracellular matrix molecule that drives progression of many types of human cancer, but the basis for its actions remains obscure. In this study, we describe a cell-autonomous signaling mechanism explaining how tenascin-C promotes cancer cell migration in the tumor micro-environment. In a murine xenograft model of advanced human osteosarcoma, tenascin-C and its receptor integrin alpha 9 beta 1 were determined to be essential for lung metastasis of tumor cells. We determined that activation of this pathway also reduced tumor cell-autonomous expression of target genes for the transcription factor YAP. In clinical specimens, a genetic sig-nature comprising four YAP target genes represents prognostic impact. Taken together, our results illuminate how tumor cell deposition of tenascin-C in the tumor microenvironment promotes invasive migration and metastatic progression. Significance: These results illuminate how the extracellular matrix glycoprotein tenascin-C in the tumor microenvironment promotes invasive migration and metastatic progression by employing integrin alpha 9 beta 1, abolishing actin stress fiber formation, inhibiting YAP and its target gene expression, with potential implications for cancer prognosis and therapy. (C) 2017 AACR.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 1 区 医学
小类 | 1 区 肿瘤学
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 肿瘤学
JCR分区:
出版当年[2016]版:
Q1 ONCOLOGY
最新[2024]版:
Q1 ONCOLOGY

影响因子: 最新[2024版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者单位: [1]INSERM, Hop Civil, Inst Hematol & Immunol, U1109,MN3T, Strasbourg, France [2]Univ Strasbourg, Strasbourg, France [3]Univ Strasbourg, LabEx Medalis, Strasbourg, France [4]FMTS, Strasbourg, France [5]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Tongji Canc Res Inst,Wuhan,Hubei,Peoples R China [6]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Dept Gastrointestinal Surg,Wuhan,Hubei,Peoples R China
通讯作者:
通讯机构: [1]INSERM, Hop Civil, Inst Hematol & Immunol, U1109,MN3T, Strasbourg, France [2]Univ Strasbourg, Strasbourg, France [3]Univ Strasbourg, LabEx Medalis, Strasbourg, France [4]FMTS, Strasbourg, France [*1]INSERM, 1 Pl Hop, F-67091 Strasbourg, France
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:622 今日访问量:0 总访问量:452 更新日期:2025-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)